Central Clinical School had 7 successful project grant submissions, 3 Early Career Fellowships and one Research Fellowship in 2015’s National Health and Medical Research Council (NHMRC) funding announcement.The Minister for Health Susan Ley MP said the funding will support 836 new research grants worth more than $630 million.
Medical researchers at Monash University attracted a total of $76.9 million dollars in funding from the NHMRC, ranked second in Australia in project grants and third for the total amount funded in this year’s round.
Congratulations to the CCS Grant and Fellowship recipients:
Early Career Fellowships
 |
| Dr Janine Trevillyan |
- Dr Janine Trevillyan (Infectious Diseases): Eliminating excess cardiovascular risk in people living with HIV.
- Dr Stuart Lee (Monash Alfred Psychiatry research centre): Skill building interventions to address barriers to social inclusion for people with schizophrenia
- Dr Jason Ong (Melbourne Sexual Health Centre): Thinking outside the box: Economic evaluation of innovative strategies to expand HIV testing in men who have sex with men
- Associate Professor Robert Andrews (Australian Centre for Blood Diseases): Vascular mechanisms of human disease
Project Grants
 |
| Prof Paul Myles |
 |
| A/Prof Jody Haigh |
 |
| Prof Robyn O'Hehir |
- Professor Paul Myles (Anaesthesia and Perioperative Medicine): IV iron for treatment of anaemia before cardiac surgery (ITACS Trial)
- Professor Robyn O'Hehir (Allergy, Immunology and Respiratory medicine): Phase I/IIa trials of a novel T-cell epitope-based peptide therapy for peanut allergy
- Dr Charbel Darido (Medicine): Stratification of therapies in HNSCC through discovery of molecular signatures
- Professor Stephen Jane (Medicine): Identification of factors critical for maintenance of the epidermal barrier
- Associate Professor Jody Haigh (Australian Centre for Blood Diseases): Role of ZEB/NuRD interactions in haematopoiesis and lymphoid malignancies
- Associate Professor Margaret Hibbs (Immunology and Pathology): Characterisation of emerging new signaling networks that underlie COPD phenotypes
- Prof Magdalena Plebanski (Immunology and Pathology): A new anti-diabetes drug as a novel therapy for ovarian cancer
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.